Ambev SA (ADR) (ABEV) Analysts See $0.06 EPS; Shorts at Bruker (BRKR) Raised By 0.29%

October 6, 2017 - By Marguerite Chambers

Analysts expect Ambev SA (ADR) (NYSE:ABEV) to report $0.06 EPS on October, 26 before the open.They anticipate $0.00 EPS change or 0.00% from last quarter’s $0.06 EPS. ABEV’s profit would be $943.02 million giving it 27.83 P/E if the $0.06 EPS is correct. After having $0.04 EPS previously, Ambev SA (ADR)’s analysts see 50.00% EPS growth. It closed at $6.68 lastly. It is down 10.52% since October 6, 2016 and is uptrending. It has underperformed by 6.18% the S&P500.

Bruker Corporation (NASDAQ:BRKR) had an increase of 0.29% in short interest. BRKR’s SI was 2.59 million shares in October as released by FINRA. Its up 0.29% from 2.58 million shares previously. With 455,700 avg volume, 6 days are for Bruker Corporation (NASDAQ:BRKR)’s short sellers to cover BRKR’s short positions. The SI to Bruker Corporation’s float is 2.49%. The stock increased 0.63% or $0.19 during the last trading session, reaching $30.52. About shares traded. Bruker Corporation (NASDAQ:BRKR) has risen 0.54% since October 6, 2016 and is uptrending. It has underperformed by 16.16% the S&P500.

Among 5 analysts covering AmBev SA (NYSE:ABEV), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. AmBev SA had 7 analyst reports since September 17, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, October 10 by Goldman Sachs. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Thursday, August 18. The firm earned “Equal Weight” rating on Thursday, November 3 by Barclays Capital. As per Thursday, November 10, the company rating was upgraded by JP Morgan. The stock has “Hold” rating by Barclays Capital on Friday, July 28. The rating was upgraded by Credit Suisse on Tuesday, September 12 to “Outperform”.

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil firm engaged in the brewing sector. The company has market cap of $104.99 billion. The Firm produces and sells beer, carbonated soft drinks and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. It has a 8.35 P/E ratio. The Company’s activities are divided into three divisions: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as activities in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.

Since May 16, 2017, it had 3 insider purchases, and 2 selling transactions for $547,360 activity. Another trade for 3,200 shares valued at $83,631 was bought by LAUKIEN FRANK H. 19,900 Bruker Corporation (NASDAQ:BRKR) shares with value of $557,889 were sold by VAN INGEN CHRIS. 73,724 shares valued at $2.04M were sold by Munch Mark on Thursday, June 8.

Among 15 analysts covering Bruker (NASDAQ:BRKR), 3 have Buy rating, 3 Sell and 9 Hold. Therefore 20% are positive. Bruker had 34 analyst reports since August 20, 2015 according to SRatingsIntel. The stock of Bruker Corporation (NASDAQ:BRKR) has “Hold” rating given on Thursday, January 7 by Deutsche Bank. As per Sunday, September 10, the company rating was maintained by Jefferies. The stock has “Buy” rating by Stifel Nicolaus on Thursday, November 12. As per Wednesday, December 14, the company rating was downgraded by JP Morgan. The firm earned “Buy” rating on Friday, June 9 by Jefferies. BTIG Research maintained the shares of BRKR in report on Thursday, September 17 with “Buy” rating. Goldman Sachs initiated the stock with “Sell” rating in Tuesday, September 26 report. Bank of America downgraded the stock to “Underperform” rating in Tuesday, April 5 report. The rating was maintained by BTIG Research with “Buy” on Thursday, August 20. As per Friday, August 4, the company rating was maintained by Jefferies.

Investors sentiment increased to 1.14 in 2017 Q2. Its up 0.29, from 0.85 in 2017Q1. It increased, as 22 investors sold Bruker Corporation shares while 58 reduced holdings. 31 funds opened positions while 60 raised stakes. 100.40 million shares or 2.18% less from 102.64 million shares in 2017Q1 were reported. Ameriprise Financial Inc has invested 0% of its portfolio in Bruker Corporation (NASDAQ:BRKR). Smithfield Co holds 4,770 shares. Bluecrest Cap Management holds 40,714 shares or 0.05% of its portfolio. Highbridge Mngmt Limited Liability Company has 0.03% invested in Bruker Corporation (NASDAQ:BRKR). State Of Wisconsin Board invested in 0% or 20,700 shares. Fifth Third Fincl Bank stated it has 14,173 shares. Utd Services Automobile Association stated it has 285,000 shares. Cantab Capital Prtn Ltd Liability Partnership owns 19,021 shares or 0% of their US portfolio. Point72 Asset Mgmt Lp reported 616,600 shares. Needham Inv Mngmt Ltd Liability Company has invested 0.08% in Bruker Corporation (NASDAQ:BRKR). Td Asset stated it has 452,768 shares or 0.02% of all its holdings. 3,840 were reported by Sg Americas Securities Ltd Llc. Invesco owns 0% invested in Bruker Corporation (NASDAQ:BRKR) for 92,584 shares. Amer has 0% invested in Bruker Corporation (NASDAQ:BRKR). Jpmorgan Chase & Com holds 0% or 243,289 shares.

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. The company has market cap of $4.83 billion. The Company’s divisions include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. It has a 30.59 P/E ratio. The Bruker BioSpin Group segment designs, makes and distributes enabling life science tools.